COMMITTEE MEETING 2
Wednesday, May 21, 2025
OPEN SESSION
| 10:00–11:00 | Discussion with Sponsors |
| Marcia McNutt, President, NAS | |
| David Spergel, President, Simons Foundation | |
| 11:00–11:15 | Break |
| 11:15–11:45 | OSTP Perspectives |
| Lynne Parker, Principal Deputy Director, White House Office of Science and Technology Policy | |
| 11:45–12:45 | Lunch |
| 12:45–1:45 | Professional Societies/Advocacy Groups |
| Matt Owens, President, COGR | |
| Michele Masucci, Vice Chancellor for Research and Economic Development, University of Maryland System |
| Alexandra Albinak, Associate Vice Provost for Research Administration, Johns Hopkins University; Co-Chair, Executive Committee, Federal Demonstration Partnership (FDP) | |
| 1:45–3:00 | Barriers and Challenges in Research Regulations |
| Moderator: Stuart Shapiro, Dean and Professor, Bloustein School of Planning and Public Policy, Rutgers University | |
| Susan Garfinkel, Consultant Owner, Research Integrity Partners; Former Senior Advisor to the Director, Office of Research Integrity | |
| Roger Nober, Director, Regulatory Studies Center, George Washington University | |
| Susan Sedwick, Senior Consulting Specialist, Attain Partners | |
| 3:00–3:30 | Break |
Friday, June 6, 2025 (Eastern Standard Time)
OPEN SESSION
| 3:00–4:00 | Conversation with Federal Research Compliance Officers (Members of the Interagency Working Group for the Common Rule) |
| Anne Andrews, Director, Research Protections Office, NIST Scientific Integrity Officer, National Institute of Standards and Technology (NIST) | |
| Stephanie Bruce, Director, Office for Human Research Protections and Bioethics, Office of the Under Secretary for Research and Engineering, Department of Defense (DOD) | |
| Natalie Klein, Acting Director, Department of Health and Human Services Office for Human Research Protections (OHRP) |
| 4:00–5:00 | Operation Warp Speed: Lessons Learned |
| Kevin Bugin, Head of Global Regulatory Policy and Intelligence, Amgen; Former Deputy Director of Operations, Office of New Drugs, FDA; Former Chief of Staff, “Operation Warp Speed” |
This page intentionally left blank.